Prev Arrow Stocks

IDEX Corporation ($IEX) Stock Forecast: Up 7.1% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is IDEX Corporation?

IDEX Corporation (IEX) is a company that operates in various industrial sectors, including Health & Science Technologies. Today, the stock of IEX experienced a strong bullish movement in the market.

Why is IDEX Corporation going up?

IEX stock is up 7.1% on Apr 29, 2026 16:40

  • IDEX Corporation reported strong financial performance in Q1 2026, exceeding revenue and EPS expectations, resulting in a notable increase in its stock value.
  • The company's excellent results in its Health & Science Technologies division, along with robust orders and profitability, generated investor confidence and pushed the stock price upwards.
  • IDEX's strategic emphasis on key markets, ongoing innovation, and efficient capital utilization were identified as crucial elements in its sustained growth, despite global uncertainties.
  • The company's revised full-year EPS forecast and positive future prospects boosted investor trust and bolstered the bullish trend in IEX's stock price.

IEX Price Chart

IEX Technical Analysis

IEX News

Earnings call transcript: IDEX beats Q1 2026 forecasts, stock jumps

IDEX Corporation reported strong Q1 2026 results, surpassing EPS and revenue forecasts, which led to a 7.21% stock surge in pre-market trading. The company raised its full-year EPS guidance for 2026, driven by robust performance in its Health & Science Technologies segment and strategic focus on advantage markets. Executives highlighted consistent innovation, effective capital deployment, and the strong backlog in HST as key factors for continued optimism despite some geopolitical uncertainties.

https://www.investing.com/news/transcripts/earnings-call-transcript-idex-beats-q1-2026-forecasts-stock-jumps-93CH-4645790

0 Missing News Article Image Earnings call transcript: IDEX beats Q1 2026 forecasts, stock jumps

IDEX (IEX) Q1 2026 results: sales rise 9% to $887 million

IDEX Corporation (NYSE:IEX) reported strong financial results for Q1 2026, with net sales increasing 9% to $887 million and organic growth of 5%. The company achieved record orders totaling $988 million, an increase of 13%, driven by demand across its industrial segments. Profitability also improved, with diluted EPS rising 28% to $1.61, and IDEX returned $129 million to shareholders through repurchases and dividends.

https://grafa.com/en/news/united-states/idex-corp-iex-q1-2026-earnings-record-orders-guidance-increase

1 News Article Image IDEX (IEX) Q1 2026 results: sales rise 9% to $887 million

Idex Releases Q1 2026 Financial Results

Idex Corporation reported strong first-quarter 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $2.00 per share against a $1.79 forecast. The company achieved $886.9 million in revenue, a 9.0% increase year-over-year, driven largely by its Health & Science Technologies segment. Idex also provided full-year adjusted EPS guidance between $8.35 and $8.55, reflecting confidence in its continued performance.

https://news.alphastreet.com/idex-releases-q1-2026-financial-results/

2 News Article Image Idex Releases Q1 2026 Financial Results

Earnings Flash (IEX) IDEX Corporation Reports Q1 Revenue $886.9M, vs. FactSet Est of $845.6M

IDEX Corporation announced its Q1 revenue reached $886.9 million, surpassing FactSet's estimate of $845.6 million. The company also reported Q1 adjusted EPS of $2.00 per share, exceeding the FactSet estimate of $1.77. For Q2, IDEX expects adjusted EPS in the range of $2.07 to $2.12, and an adjusted EPS range of $8.35 to $8.55 for the full year 2026, against an analyst estimate of $8.26.

https://www.marketscreener.com/news/earnings-flash-iex-idex-corporation-reports-q1-revenue-886-9m-vs-factset-est-of-845-6m-ce7f59d3d180f52c

3 News Article Image Earnings Flash (IEX) IDEX Corporation Reports Q1 Revenue $886.9M, vs. FactSet Est of $845.6M

Earnings Flash (IEX) IDEX Corporation Posts Q1 Adjusted EPS $2.00 per Share, vs. FactSet Est of $1.77

IDEX Corporation reported its first-quarter adjusted EPS at $2.00 per share, surpassing the FactSet estimate of $1.77. The company's Q1 revenue also beat expectations, coming in at $886.9 million against an estimated $845.6 million. Additionally, IDEX provided forward-looking guidance, expecting an adjusted EPS range of $2.07-$2.12 for Q2 and $8.35-$8.55 for the full year 2026.

https://www.marketscreener.com/news/earnings-flash-iex-idex-corporation-posts-q1-adjusted-eps-2-00-per-share-vs-factset-est-of-1-7-ce7f59d3d180f526

4 News Article Image Earnings Flash (IEX) IDEX Corporation Posts Q1 Adjusted EPS $2.00 per Share, vs. FactSet Est of $1.77

IDEX Corporation Price History

05.00.2026 - IEX Stock was up 2.0%

  • A notable surge in Harvey Investment Co. LLC's ownership in IEX, coupled with IEX's announcement of a $1.0 billion share repurchase scheme and a quarterly dividend, likely bolstered investor confidence, driving the bullish market movement.
  • Analysts' "Moderate Buy" rating and the average price target of $196.86 contributed to the positive sentiment surrounding IEX, indicating a promising outlook for the company's future performance.
  • Emphasizing IEX as a stable and growth-oriented investment choice, focusing on indispensable products, strong cash flow, and reliable dividends, may have attracted more long-term investors, elevating the stock value.
  • Overall, the combination of a substantial increase in ownership by a significant investor, favorable analyst ratings, and the depiction of IEX as a dependable option for stability and growth likely played a pivotal role in today's bullish market movement of IDEX Corporation.

02.02.2026 - IEX Stock was up 1.6%

  • One major fund reduced its stake in IDEX Corporation, while other prominent funds like Nordea and Nuance increased their positions, reflecting mixed sentiments among institutional investors.
  • Another fund significantly increased its stake in IDEX following the company's strong quarterly earnings beat and positive guidance, showing confidence in its future performance.
  • Additionally, a different fund also boosted its position in IDEX after the company surpassed earnings estimates and provided optimistic guidance, reflecting the positive market sentiment towards the stock.
  • Analysts raised earnings estimates for IDEX, projecting strong future performance based on the company's recent financial results and analyst upgrades, further supporting the bullish movement in the stock.

04.01.2026 - IEX Stock was up 5.2%

  • IDEX (IEX) experienced a strong uptrend today supported by its robust Q4 2025 performance and optimistic projections for 2026.
  • The company's success in the HST segment, fueled by demand from data centers and semiconductors, notably influenced the positive market movement.
  • Significant order increase in AI-related ventures, surpassing earnings and revenue forecasts, reinforced investor faith in IDEX.
  • Despite maintaining a Zacks Rank #4 (Sell) owing to adjustments in estimates, the favorable financial outcomes and outlook are likely to have eclipsed this, prompting the bullish market activity.

29.03.2026 - IEX Stock was up 7.1%

  • IDEX Corporation reported strong financial performance in Q1 2026, exceeding revenue and EPS expectations, resulting in a notable increase in its stock value.
  • The company's excellent results in its Health & Science Technologies division, along with robust orders and profitability, generated investor confidence and pushed the stock price upwards.
  • IDEX's strategic emphasis on key markets, ongoing innovation, and efficient capital utilization were identified as crucial elements in its sustained growth, despite global uncertainties.
  • The company's revised full-year EPS forecast and positive future prospects boosted investor trust and bolstered the bullish trend in IEX's stock price.

17.08.2025 - IEX Stock was down 1.6%

  • The launch of IDEX Biometrics ASA's new product portfolio for payment and access solutions did not seem to positively impact IEX's stock price.
  • The continuous decline in IEX's stock price may be attributed to the overall downward trend the company has been experiencing since April 2024.
  • Despite the innovative advancements in biometric authentication offerings by IDEX Biometrics ASA, investors may be more focused on the overall performance and market sentiment towards IEX Corporation, leading to the bearish movement in the stock price.
  • The rising downside risk stated to have further contributed to the bearish movement in IEX's stock today.

30.06.2025 - IEX Stock was down 8.1%

  • Despite surpassing Q2 earnings and revenue expectations, IDEX (IEX) saw a downward trend in the market recently.
  • The registration of a share capital increase and a partnership with Savyint Group in Vietnam likely influenced investor confidence positively.
  • However, uncertainties related to an upcoming extraordinary general meeting and the company's future plans might have led investors to secure profits, contributing to the market decline.
  • The market reaction to the Q2 earnings report and how the company performed in comparison to expectations could have also impacted the recent market movement.

29.09.2025 - IEX Stock was up 7.3%

  • IEX is expected to post Q3 earnings with solid gains in Health & Science and Fire & Safety, which could have boosted investor confidence in the company's performance.
  • Despite not meeting the specific criteria for a likely earnings beat according to market expectations, investors might be optimistic about the overall growth potential of IEX.
  • The positive sentiment surrounding IEX's diverse product offerings and potential growth in key sectors could have contributed to the bullish movement in the stock today.

24.02.2026 - IEX Stock was up 1.0%

  • IDEX Corp's stock demonstrated strong performance compared to competitors and major market indices, reflecting high investor confidence in the company.
  • The favorable movement may be linked to the company surpassing analyst expectations in its Q4 earnings, leading to multiple price target upgrades.
  • Although Nordea Investment Management AB reduced its stake in the company, this factor did not deter positive market sentiment towards IDEX Corp.
  • Previous days of losses could be viewed as a short-term correction or profit-taking, with today's increase suggesting a return of bullish investor sentiment.

30.06.2025 - IEX Stock was down 11.4%

  • Despite surpassing Q2 earnings estimates and experiencing revenue growth, the stock saw a bearish movement, indicating that the market may have had higher expectations.
  • The registration of a share capital increase could have led to dilution concerns among investors, impacting the stock price negatively.
  • The partnership with Savyint Group for next-gen access cards is a positive development, but it seems that the market sentiment was influenced more by other factors leading to the bearish movement.
  • The overall market reaction suggests that despite positive earnings and strategic partnerships, other factors such as margin slip and rising costs might have weighed on investor confidence, resulting in the bearish movement.

30.06.2025 - IEX Stock was down 6.3%

  • The registration of a share capital increase might have led to dilution concerns among investors, impacting the stock negatively.
  • Despite the partnership announcement with Savyint Group, the market may have reacted negatively due to uncertainties surrounding the implementation and success of the new technology.
  • The anticipation of IEX posting Q2 earnings could have created volatility in the stock price, with investors potentially taking profits before the release.
  • The high expectations for an earnings beat might have resulted in a "sell the news" scenario, where investors sold off shares after the earnings report, even if the results were positive.

29.09.2025 - IEX Stock was up 5.2%

  • Idex (IEX) reported better-than-expected Q3 earnings and revenue, surpassing estimates by +5.18% and +2.37% respectively.
  • The strong performance was driven by solid gains in the Health & Science and Fire & Safety segments, offsetting any softness in the Fluid & Metering segment.
  • Investors reacted positively to the news, leading to a bullish movement in the stock as the results hint at a promising future for Idex Corporation.
  • The market seems to be optimistic about Idex's ability to navigate through challenges and capitalize on opportunities in its various business segments.

29.03.2026 - IEX Stock was up 6.8%

  • Robust first-quarter 2026 financial results were reported by Idex Corporation, surpassing expectations with growth in adjusted earnings and revenue.
  • The company's strong performance was driven by its Health & Science Technologies segment, demonstrating its adeptness at seizing market opportunities.
  • Positive forward-looking guidance from Idex, with an increased adjusted EPS range for both the second quarter and full year 2026, bolstered investor confidence and contributed to the stock's upward trajectory.
  • The high volume of orders, revenue growth, and improved profit outlook all indicate a favorable future for Idex Corporation, enhancing investor certainty and fueling the stock's upward momentum.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.